Bio-Techne Earnings
NASDAQ: TECHHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Bio-Techne earnings summary
In its most recent report on Nov 11, 2026 (Sep/2026), TECH posted EPS of $0.36 versus the $0.40 consensus estimate, a negative surprise of 10.0%. Bio-Techne beat the consensus EPS estimate in 0 of the last 3 quarters, with a median surprise of -10.0%. Quarterly EPS is up 12.5% from the same quarter a year earlier.
Across the last 16 reports, TECH shares moved an average of 4.4% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
TECH earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 11, 2026 | $0.40 | $0.36 | -10.0% | -0.2% |
| Nov 6, 2026 | $0.40 | $0.37 | -7.5% | +0.0% |
| Nov 4, 2026 | $0.40 | $0.36 | -10.0% | +0.0% |
| Aug 24, 2026 | — | $0.36 | — | +0.1% |
| May 6, 2026 | — | $0.32 | — | -10.5% |
| Feb 4, 2026 | — | $0.24 | — | -10.3% |
| Nov 5, 2025 | — | $0.24 | — | +3.4% |
| Aug 22, 2025 | — | $-0.11 | — | -4.3% |
| May 8, 2025 | — | $0.14 | — | -1.6% |
| Feb 6, 2025 | — | $0.22 | — | -9.4% |
| Nov 5, 2024 | — | $0.21 | — | -11.0% |
| Aug 22, 2024 | — | $0.26 | — | +2.4% |
| May 6, 2024 | — | $0.31 | — | +3.6% |
| Feb 7, 2024 | — | $0.17 | — | +5.4% |
| Nov 7, 2023 | — | $0.31 | — | +6.2% |
| Aug 23, 2023 | — | $0.47 | — | -1.7% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.